51 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18608369 | ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY | O DELL, DAVID K | 1621 | Final Rejection | Mar 18, 2024 |
| 18394091 | ANTIGEN-BINDING MOLECULE AND COMBINATION | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Dec 22, 2023 |
| 18533622 | METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A MEK INHIBITOR | NESTOR, DONNA MICHELLE | 1627 | Non-Final OA | Dec 08, 2023 |
| 18567435 | FORMULATION CONTAINING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | CHONG, YONG SOO | 1623 | Non-Final OA | Dec 06, 2023 |
| 18557906 | SYRINGE | AKAR, SERKAN | 3797 | Non-Final OA | Oct 27, 2023 |
| 18480730 | ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Oct 04, 2023 |
| 18458292 | THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Aug 30, 2023 |
| 18346975 | ANTI-HLA-DQ2.5 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Jul 05, 2023 |
| 18268470 | METHOD FOR SCREENING FOR CANDIDATE MOLECULE CAPABLE OF FORMING COMPLEX IN CONJUNCTION WITH PLURALITY OF TARGET MOLECULES | PHAM, KHAI QUYNH TIEN | 1684 | Non-Final OA | Jun 20, 2023 |
| 18266665 | METHOD FOR MEASURING RELATIVE fu RATIO BY DYNAMIC ANALYSIS | NGUYEN, NAM P | 1678 | Non-Final OA | Jun 12, 2023 |
| 18034429 | THERAPEUTIC AGENT FOR PERIPARTUM CARDIOMYOPATHY | ALLEN, MARIANNE P | 1647 | Non-Final OA | Apr 28, 2023 |
| 18023038 | HETERODIMER FC POLYPEPTIDE | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Feb 24, 2023 |
| 18023246 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF DIALYSIS PRURITUS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Feb 24, 2023 |
| 18022342 | HETERODIMER FC POLYPEPTIDE | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Feb 21, 2023 |
| 18020656 | ONE-ARMED ANTIGEN-BINDING MOLECULES AND USES THEREOF | BERHANE, SELAM | 1675 | Non-Final OA | Feb 10, 2023 |
| 18018460 | METHOD FOR MEASURING PHARMACOKINETICS OF AGENT LABELED WITH NON-RADIOACTIVE SUBSTANCE | XU, XIAOYUN | 1797 | Non-Final OA | Jan 27, 2023 |
| 18010611 | SITE SPECIFIC NOTCH-ACTIVATING MOLECULE AND USES THEREOF | CHASE, CAROL ANN | 1646 | Final Rejection | Dec 15, 2022 |
| 18010615 | ANTI-T CELL ANTIGEN-BINDING MOLECULE FOR USE IN COMBINATION WITH ANGIOGENESIS INHIBITOR | AEDER, SEAN E | 1642 | Non-Final OA | Dec 15, 2022 |
| 17928759 | EFFICIENT PEPTIDE CONDENSATION METHOD FOR DIFFICULT SEQUENCES | NIEBAUER, RONALD T | 1658 | Non-Final OA | Nov 30, 2022 |
| 17926673 | IMPROVED GRANZYME B VARIANT | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Nov 21, 2022 |
| 17914855 | IMMUNE ACTIVATING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF | DRISCOLL, MAUREEN VARINA | 1644 | Non-Final OA | Sep 27, 2022 |
| 17914432 | METHOD FOR PRODUCING MULTISPECIFIC ANTIGEN-BINDING MOLECULES | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Sep 26, 2022 |
| 17913899 | CLAUDIN-6 TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF | NICKOL, GARY B | 1643 | Non-Final OA | Sep 23, 2022 |
| 17933879 | IMMUNOACTIVATING ANTIGEN-BINDING MOLECULE | SKELDING, ZACHARY S | 1644 | Non-Final OA | Sep 21, 2022 |
| 17897946 | TREATMENTS FOR ATOPIC DERMATITIS | JIANG, DONG | 1674 | Non-Final OA | Aug 29, 2022 |
| 17896758 | PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE | FUBARA, BLESSING M | 1613 | Non-Final OA | Aug 26, 2022 |
| 17797540 | METHODS FOR PRODUCING AND/OR ENRICHING RECOMBINANT ANTIGEN-BINDING MOLECULES | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Aug 04, 2022 |
| 17788506 | METHOD FOR SYNTHESIZING PEPTIDE COMPOUND | REYNOLDS, FRED H | 1658 | Final Rejection | Jun 23, 2022 |
| 17846672 | Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY | DAHLE, CHUN WU | 1641 | Final Rejection | Jun 22, 2022 |
| 17787809 | COMPOSITION FOR TRANSLATION, AND METHOD FOR PRODUCING PEPTIDE | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Jun 21, 2022 |
| 17784735 | SYSTEM FOR DETECTING EXTRACELLULAR PURINERGIC RECEPTOR LIGAND, AND NON-HUMAN ANIMAL HAVING THE SYSTEM INTRODUCED THEREINTO | ROGERS, ERIC JASON | 1638 | Final Rejection | Jun 13, 2022 |
| 17756756 | PACKAGE OPENING SYSTEM | AYALA, FERNANDO A | 3724 | Final Rejection | Jun 01, 2022 |
| 17773733 | CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION | SABILA, MERCY HELLEN | 1654 | Non-Final OA | May 02, 2022 |
| 17312296 | AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF | D' AMBROSIO, THEA | 1654 | Final Rejection | Apr 29, 2022 |
| 17768053 | AN ANTIBODY, A PHARMACEUTICAL COMPOSITION, AND A METHOD | HOWARD, ZACHARY C | 1674 | Final Rejection | Apr 11, 2022 |
| 17767742 | METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE LIKE CONTAINING SAME | WEDDINGTON, KEVIN E | 1629 | Non-Final OA | Apr 08, 2022 |
| 17716467 | ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SUGAR CHAIN RECEPTOR-BINDING DOMAIN | LI, RUIXIANG | 1674 | Final Rejection | Apr 08, 2022 |
| 17766280 | INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO | SANG, HONG | 1646 | Non-Final OA | Apr 04, 2022 |
| 17763948 | PHARMACEUTICAL COMPOSITION WHICH CAN BE USED FOR PREVENTION AND/OR TREATMENT OF ACQUIRED HEMOPHILIA A, AND PRODUCT COMPRISING SAID PHARMACEUTICAL COMPOSITION | TAYLOR, LIA ELAN | 1641 | Final Rejection | Mar 25, 2022 |
| 17555997 | TREATMENT OF SKIN LESIONS AND PRURITUS IN PRURIGO NODULARIS PATIENTS | JIANG, DONG | 1674 | Non-Final OA | Dec 20, 2021 |
| 17616421 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, PROGRAM, AND METHOD FOR PRODUCING ANTIGEN-BINDING MOLECULE OR PROTEIN | PLAYER, ROBERT AUSTIN | 1686 | Non-Final OA | Dec 03, 2021 |
| 17438496 | ANTI-HLA-DQ2.5 ANTIBODY | DIBRINO, MARIANNE | 1641 | Non-Final OA | Sep 13, 2021 |
| 17417822 | MUTATED tRNA FOR CODON EXPANSION | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Jun 24, 2021 |
| 17290439 | HER2 S310F SPECIFIC ANTIGEN-BINDING MOLECULES | FAUST, AMBER KATHLEEN | 1643 | Final Rejection | Apr 30, 2021 |
| 17271239 | ANTIBODY HALF-MOLECULE, AND METHOD FOR INHIBITING HOMODIMER FORMATION OF ANTIBODY HALF-MOLECULE | DAHLE, CHUN WU | 1641 | Final Rejection | Feb 25, 2021 |
| 17266029 | METHOD FOR CULTURING CANCER TISSUE OR TISSUE ANALOGOUS TO CANCER TISSUE | IVICH, FERNANDO NMN | 1678 | Final Rejection | Feb 04, 2021 |
| 17262105 | TARGET CELL SPECIFIC CYTOSOL-PENETRATING ANTIGEN-BINDING MOLECULES | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Jan 21, 2021 |
| 17144342 | ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS | SANG, HONG | 1646 | Non-Final OA | Jan 08, 2021 |
| 15734755 | ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM | CHASE, CAROL ANN | 1646 | Final Rejection | Dec 03, 2020 |
| 17058896 | LIGAND-BINDING MOLECULE CONTAINING SINGLE DOMAIN ANTIBODY | EDGINGTONGIORDANO, FRANCESCA | 1643 | Non-Final OA | Nov 25, 2020 |
| 16692676 | ANTIGEN-BINDING MOLECULE HAVING REGULATED CONJUGATION BETWEEN HEAVY-CHAIN AND LIGHT-CHAIN | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Nov 22, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial